At a glance
ClinicalIndex Comparison RecordN/ATerminated· 16 enrolled
Drug / intervention
AFib detection with wearable smart watchother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Accuracy of Rhythm Detection and Managing Data Deluge by a Wearable Smart Watch for Cardiac Arrhythmias (The WATCH-RHYTHM Study)
In Brief
A clinical study evaluating AFib detection with wearable smart watch for Atrial Fibrillation. Terminated early, enrolled 16 participants across 1 site.
Signals
Trial was terminated early
Detailed Summary
It is an attempt to see the reliability of the Wearable Smart Watch in identifying atrial fibrillation and other arrhythmias compared to the data detected from ILRs.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation
CountriesUnited States
Collaborators--
Timeline
N/ATerminatedFinished
202120222023202420252026
First PostedAug 2020
Enrollment StartJan 2021
Primary CompletionMar 2021
TodayJul 2026
First PostedAug 5, 2020
Enrollment StartJan 6, 2021
Primary CompletionMar 16, 2021
TodayJul 1, 2026
Enrollment to primary: 2 monthsPosted 5.9 years ago
Interventions
AFib detection with wearable smart watchother
Patients will transmit two rhythm strips every day through both the devices and additional transmission whenever they have symptoms (palpitations, skipped beats, shortness of breath and chest pain). The transmitted rhythm strips are de-identified and analyzed after assigning a unique ID for research purposes.